Finally, the use of CSF pTau181 as the pathology term in the interaction model focuses the analysis on tau-related processes that are closely associated with amyloid-β deposition, and may not capture reserve mechanisms that primarily operate through vascular lesions, TDP-43, or other non-AD pathologies. The gene discussed is MAPT; the disease is Alzheimer disease.